Ligand validation:4K3N

2PE: NONAETHYLENE GLYCOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4K3N_2PE_H_1006	35%	96%	0.148	0.855	0.21	0.15	-	-	1	0	89%	0.8929
4K3N_2PE_B_1006	32%	96%	0.178	0.863	0.18	0.17	-	-	0	0	93%	0.9286
4K3N_2PE_F_1010	22%	94%	0.139	0.878	0.21	0.22	-	-	1	0	32%	0.3214
4K3N_2PE_C_1009	21%	95%	0.153	0.881	0.16	0.24	-	-	2	0	32%	0.3214
4K3N_2PE_B_1007	18%	98%	0.174	0.872	0.06	0.23	-	-	0	0	36%	0.3571
4K3N_2PE_D_1010	14%	96%	0.198	0.843	0.2	0.15	-	-	4	0	46%	0.4643
4K3N_2PE_D_1012	12%	96%	0.207	0.863	0.18	0.17	-	-	1	0	32%	0.3214
4K3N_2PE_E_1010	12%	97%	0.19	0.837	0.14	0.19	-	-	1	0	32%	0.3214
4K3N_2PE_D_1011	11%	90%	0.246	0.914	0.25	0.37	-	-	0	0	18%	17.86
4K3N_2PE_I_1010	11%	98%	0.178	0.823	0.15	0.12	-	-	0	0	29%	0.2857
4K3N_2PE_H_1007	10%	98%	0.191	0.812	0.21	0.08	-	-	1	0	36%	0.3571
4K3N_2PE_J_1010	8%	97%	0.222	0.809	0.21	0.11	-	-	0	0	36%	0.3571
3KQX_2PE_H_6	66%	67%	0.124	0.948	0.51	0.76	-	-	1	0	89%	0.8929
5V2O_2PE_A_102	95%	52%	0.076	0.979	0.79	1.06	-	1	0	0	100%	1
2WGG_2PE_H_1419	72%	66%	0.125	0.949	0.68	0.62	-	-	5	0	100%	1
4V1K_2PE_A_1625	69%	70%	0.108	0.928	0.51	0.66	-	-	0	0	96%	0.9464
2FTA_2PE_A_501	65%	6%	0.108	0.91	1.99	3.05	3	8	0	0	100%	1
5OYC_2PE_B_516	64%	49%	0.096	0.893	0.82	1.13	-	1	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.